Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.

MLA

Kołaczkowski, Marcin, et al. “Novel Arylsulfonamide Derivatives with 5-HT₆/5-HT₇ Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia.” Journal of Medicinal Chemistry, vol. 57, no. 11, June 2014, pp. 4543–57. EBSCOhost, https://doi.org/10.1021/jm401895u.

APA

Kołaczkowski, M., Marcinkowska, M., Bucki, A., Pawłowski, M., Mitka, K., Jaśkowska, J., Kowalski, P., Kazek, G., Siwek, A., Wasik, A., Wesołowska, A., Mierzejewski, P., & Bienkowski, P. (2014). Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia. Journal of Medicinal Chemistry, 57(11), 4543–4557. https://doi.org/10.1021/jm401895u

Chicago

Kołaczkowski, Marcin, Monika Marcinkowska, Adam Bucki, Maciej Pawłowski, Katarzyna Mitka, Jolanta Jaśkowska, Piotr Kowalski, et al. 2014. “Novel Arylsulfonamide Derivatives with 5-HT₆/5-HT₇ Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia.” Journal of Medicinal Chemistry 57 (11): 4543–57. doi:10.1021/jm401895u.